Log in  |  Register   3/19/2010

Lesson from flu vaccine

By Boston Herald Editorial Staff
Sunday, November 1, 2009 -
EmailE-mail   PrintablePrint   Comments(0) Comments   LargerSmallerText size  Bookmark and Share Share  

The production of swine flu vaccine is behind schedule, a result of a manufacturing process that took longer than expected. This would not have mattered if the Food and Drug Administration had given up its belt-and-suspenders supercaution - a fearfulness not limited to the FDA, but one that hobbles American life in many areas.

The vaccine contains no adjuvants, compounds that stimulate the immune system and thus boost the potency of the vaccine. Adjuvants are used in Europe without harm. A European dose of the vaccine is 3.75 micrograms; the U.S. dose is 15 micrograms.

 
The article you requested has been archived
 
All coverage within BostonHerald.com from the last 7 days remains free of charge. Articles do not always include original photos, charts or graphics.
» Click for access to article within the archive
Advertisement
Advertisement



Contact us  |   Print advertising  |   Online advertising  |   Herald history  |   News tips  |   Electronic edition  |   Browser upgrade  |   Home delivery  |   Herald wireless

$ave on Boston Herald Home Delivery

Jobs with Herald Media

For back copy information and more information on other collectible copies please call 617-426-3000 Ext. 7714.  Click here for Celtics, Patriots and Red Sox back copies

N.I.E. Smart Edition Mass Literacy Foundation